MYO · XBRL financial data
Myomo financial statements, every fiscal year
The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal years (MYO's year ends in late December)
| In thousands of dollars | Dec 31, 2020 | Dec 31, 2021 | †Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|
| Revenue from contracts with customers | 7,583 | 13,856 | 15,555 | 19,241 | 32,551 | 40,928 |
| Cost of revenue | 2,600 | 3,544 | 5,302 | 6,059 | 9,366 | 14,040 |
| Cost of goods and services sold | 457 | 113 | — | 65 | 216 | 109 |
| Gross profit | 4,983 | 10,312 | 10,253 | 13,182 | 23,185 | 26,888 |
| Research and development | 1,669 | 2,557 | 2,482 | 2,636 | 4,772 | 6,944 |
| Selling, general and administrative | 13,816 | 18,023 | 18,443 | 18,777 | — | — |
| General and administrative | — | — | — | 9,735 | 12,383 | 13,961 |
| Total operating expenses | 15,486 | 20,580 | 20,925 | 21,414 | 29,392 | 41,290 |
| Other operating income (expense) | — | (17) | (1) | (1) | 0 | — |
| Operating income (loss) | (10,503) | (10,268) | (10,672) | (8,232) | (6,207) | (14,402) |
| Interest expense | 219 | — | — | — | — | — |
| Other income (expense) | (1,061) | (15) | 21 | 240 | 389 | (668) |
| Income tax expense (benefit) | — | 89 | 70 | 156 | 366 | 505 |
| Net income (loss) | (11,564) | (10,372) | (10,721) | (8,148) | (6,184) | (15,574) |
| Earnings per share, basic USD per share | — | (1.89) | (1.52) | (0.28) | (0.16) | (0.37) |
| Earnings per share, diluted USD per share | — | (1.89) | (1.52) | (0.28) | (0.16) | (0.37) |
| Weighted average shares, basic thousands of shares | — | 5,830 | 7,051 | 29,499 | 37,759 | 41,856 |
| Weighted average shares, diluted thousands of shares | — | 5,830 | 7,051 | 29,499 | 37,759 | 41,856 |
- † Share count changed about 3x in the period ending 2022-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
Balance sheet
CSVFiscal years (MYO's year ends in late December)
| In thousands of dollars | Dec 31, 2020 | Dec 31, 2021 | †Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 12,241 | 15,524 | 5,346 | 6,871 | 24,372 | 14,132 |
| Short-term investments | — | — | 0 | 1,995 | 493 | 4,262 |
| Accounts receivable | 925 | 1,960 | 1,896 | 2,383 | 3,825 | 4,096 |
| Inventory | 707 | 808 | 1,400 | 1,804 | 3,166 | 3,123 |
| Prepaid and other current assets | 573 | 894 | 573 | 599 | 933 | 1,944 |
| Total current assets | 14,446 | 19,187 | 9,215 | 13,651 | 32,790 | 27,557 |
| Property and equipment, net | 95 | 275 | 194 | 176 | 1,330 | 2,213 |
| Right-of-use asset | 169 | 633 | 509 | 664 | 7,585 | 6,679 |
| Total assets | 14,710 | 20,095 | 10,162 | 14,582 | 42,244 | 38,637 |
| Current portion of long-term debt | — | — | — | — | 2,955 | 2,955 |
| Total current liabilities | 2,870 | 4,283 | 3,602 | 5,477 | 10,172 | 8,345 |
| Lease liability, non-current | 155 | 402 | 200 | 115 | 7,358 | 7,666 |
| Total liabilities | 3,144 | 4,686 | 3,803 | 5,592 | 17,530 | 27,233 |
| Accumulated deficit | (67,690) | (78,062) | (88,783) | (96,931) | (103,115) | (118,688) |
| Total stockholders' equity | 11,565 | 15,409 | 6,359 | 8,989 | 24,714 | 11,403 |
| Total liabilities and equity | 14,710 | 20,095 | 10,162 | 14,582 | 42,244 | 38,637 |
| Common shares outstanding (cover page) thousands of shares | 5,583 | 6,875 | 20,922 | 28,487 | 34,381 | 38,512 |
- † Share count changed about 3x in the period ending 2022-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
Cash flows
CSVFiscal years (MYO's year ends in late December)
| In thousands of dollars | Dec 31, 2020 | Dec 31, 2021 | †Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|
| Net income (loss) | (11,564) | (10,372) | (10,721) | (8,148) | (6,184) | (15,574) |
| Stock-based compensation | 614 | 1,096 | 1,190 | 1,116 | 874 | 2,084 |
| Net cash from operating activities | (9,033) | (9,548) | (10,234) | (6,173) | (3,290) | (14,511) |
| Purchases of property and equipment | 46 | 326 | 112 | 146 | 1,360 | 1,742 |
| Net cash from investing activities | (46) | (326) | (311) | (2,030) | 260 | (7,058) |
| Proceeds from issuing common stock | — | 1,100 | — | — | — | — |
| Net cash from financing activities | 16,781 | 13,168 | 377 | 9,713 | 20,932 | 11,427 |
| Net change in cash | 7,701 | 3,283 | (10,178) | 1,525 | 17,876 | (10,040) |
- † Share count changed about 3x in the period ending 2022-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
Compare with peers
SIC 3842 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 3842 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- Runway shows only for companies burning cash with under $10B of public float.
- * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
- A cell reading “not reported” means the filings give no figure for that quarter alone.
| Company | Cash ($K) | Revenue, quarter ($K) | Operating cash flow, quarter ($K) | Shares outstanding | Runway | Quarter |
|---|---|---|---|---|---|---|
| Myomo | 11,219 | 11,705 | (1,944)* | 39.6M | 6.9 quarters | 10-QJun 30, 2026 |
| Edap TMS | 21,542 | 13,203 | (3,691)* | 37.5M | 6.5 quarters | 10-QJun 30, 2026 |
| Orchestra BioMed Holdings | 20,472 | 88 | (19,332)* | 60.1M | 5.7 quarters | 10-QJun 30, 2026 |
| InspireMD | 15,149 | 1,771 | (10,895)* | 46.5M | 2.8 quarters | 10-QJun 30, 2026 |
| Cytosorbents | 4,413 | 9,633 | (583)* | 62.8M | 7.6 quarters | 10-QJun 30, 2026 |
| Pro Dex | 11,759 | 20,560 | 6,490 | 3.2M | — | 10-QSep 30, 2026 |
| Monogram Technologies | 12,834 | not reported | (2,297)* | 40.6M | 5.6 quarters | 10-QJun 30, 2025 |
| Sensus Healthcare | 15,186 | 2,290 | (3,133)* | 16.5M | 4.8 quarters | 10-QJun 30, 2026 |
| Mobia Medical | 177,090 | 13,505 | (15,670)* | 33.3M | 11.3 quarters | 10-QJun 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.